INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

ELI LILLY & Co

Pharmaceutical Preparations | SIC: 2834
Phone: 3172762000

CIK: 0000059478
EIN: 350470950
State Location: IN
State of Inc.: IN

NYSE:LLY

Form: SCHEDULE 13G/A

Filing Date: 23 Jul 2026
Report Date:
Accepted: 23 Jul 2026 08:12 a.m.
Accession Number: 0000316011-26-000029

Act: 34
File Number: 005-17885
Film Number: 261195594

Documents

Primary Document

Accepted: 23 Jul 2026 08:12 a.m.

0000316011-26-000029-index-headers.html

Last Modified: 23 Jul 2026 08:12 a.m.

0000316011-26-000029-index.html

Last Modified: 23 Jul 2026 08:12 a.m.

0000316011-26-000029.txt

Last Modified: 23 Jul 2026 08:12 a.m.

primary_doc.xml

Last Modified: 23 Jul 2026 08:12 a.m.